Best practice in primary care pathology: review 13

被引：3
作者：
Cabrera-Abreu, J. C. [2 ]
Smellie, W. S. A. [1 ]
Bowley, R. [3 ]
Shaw, N. [3 ]
机构：
[1] Bishop Auckland Gen Hosp, Dept Chem Pathol, Bishop Auckland DL14 6AD, Durham, England
[2] Royal Berkshire & Battle NHS Trust, Dept Clin Biochem, London, England
[3] All St Business Ctr, Sowerby Ctr Hlth Informat, Newcastle Upon Tyne, Tyne & Wear, England
来源：
JOURNAL OF CLINICAL PATHOLOGY | 2012年 / 65卷 / 02期
关键词：
SERUM TUMOR-MARKERS; BREAST-CANCER; FOLLOW-UP; CA-19-9; UTILITY; CEA; RECOMMENDATIONS; STANDARDS; DIAGNOSIS; OPTIONS;
D O I：
10.1136/jclinpath-2011-200292
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
This 13th best practice review examines tumour marker requesting primary care situations. The review is presented in question-answer format, referenced for each question. This review considers carcinoembryonic antigen carbohydrate antigen 15-3 (Ca15-3) and carbohydrate antigen 19-9 (Ca19-9). The recommendations represent a pre ' cis of guidance found using a standardised literature search of national and international guidance notes, consensus statements, health policy documents and evidence-based medicine reviews, supplemented by MEDLINE EMBASE searches to identify relevant primary research documents. They will be updated periodically to take account of new information.
引用
收藏
页码：97 / 100
页数：4
相关论文
共 36 条
  • [1] [Anonymous], GEN MED SERVICES CON
  • [2] [Anonymous], J CLIN ONCOL
  • [3] Association of Clinical Biochemists in Ireland, 2005, GUID US TUM MARK
  • [4] Basuyau JP, 2000, B CANCER, V87, P723
  • [5] THE VALUE OF CARCINOEMBRYONIC ANTIGEN MEASUREMENT IN CLINICAL-PRACTICE
    BEGENT, RHJ
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 1984, 21 (JUL) : 231 - 238
  • [6] Beretta E, 1987, CANCER, V60, P7428
  • [7] Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis
    Charatcharoenwitthaya, Phunchai
    Enders, Felicity B.
    Halling, Kevin C.
    Lindor, Keith D.
    [J]. HEPATOLOGY, 2008, 48 (04) : 1106 - 1117
  • [8] Serum tumor markers in breast cancer: Are they of clinical value?
    Duffy, MJ
    [J]. CLINICAL CHEMISTRY, 2006, 52 (03) : 345 - 351
  • [9] CA 19-9 as a marker for gastrointestinal cancers: a review
    Duffy, MJ
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 1998, 35 : 364 - 370
  • [10] Serum CEA and CA 15-3 as prognostic factors in primary breast cancer
    Ebeling, FG
    Stieber, P
    Untch, M
    Nagel, D
    Konecny, GE
    Schmitt, UM
    Fateh-Moghadam, A
    Seidel, D
    [J]. BRITISH JOURNAL OF CANCER, 2002, 86 (08) : 1217 - 1222
1234